<DOC>
	<DOCNO>NCT02072824</DOCNO>
	<brief_summary>This study design evaluate effectiveness 2 dos pregabalin reduce seizure frequency add therapy pediatric subject 1 month &lt; 4 year age refractory partial onset seizure . It hypothesize dos pregabalin demonstrate superior efficacy compare placebo reduce partial onset seizure frequency pregabalin safe well tolerate .</brief_summary>
	<brief_title>A Safety , Efficacy , Tolerability Trial Pregabalin Add-On Treatment Pediatric Subjects &lt; 4 Years Age With Partial Onset Seizures .</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subject must 3 partial onset seizure month prior screen . Subject must 2 partial onset seizures 48 hour baseline phase . Signed Informed Consent . On 13 stable antiepileptic drug screen . Primary generalize seizure include clonic , tonic , clonictonic , absence , febrile seizure , infantile spasm . LennoxGasteau , BECTS , Dravet 's syndrome . Status epliepticus within 1 year screening . Any change AED regimen 7 day screen . Progressive structural central nervous system ( CNS ) lesion progressive encephalopathy . Progressive error metabolism .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Partial Onset Seizures</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pregabalin</keyword>
	<keyword>Lyrica</keyword>
	<keyword>Adjunctive treatment</keyword>
	<keyword>Placebo control</keyword>
	<keyword>blind</keyword>
	<keyword>Eligibility Criteria</keyword>
</DOC>